Appeal No. 2001-0598 Page 9 Application No. 08/451,090 claimed compound, in the expectation that compounds similar in structure will have similar properties. In re Gyurik, 596 F. 2d 1012, 1018, 201 USPQ 552, 557 (CCPA 1979); See In re May, 574 F. 2d 1082, 1094, 197 USPQ 601, 611 (CCPA 1978); In re Hoch, 57 CCPA 1292, 1296, 428 F. 2d 1341, 1344, 166 USPQ 406, 409 (1970). … When prior art compounds essentially "bracketing" the claimed compounds in structural similarity are all known as pesticides, one of ordinary skill in the art would clearly be motivated to make those claimed compounds in searching for new pesticides. Stated differently, “[i]n obviousness rejections based on close similarity in chemical structure, the necessary motivation to make a claimed compound, and thus the prima facie case of obviousness, rises from the expectation that compounds similar in structure will have similar properties.” In re Lalu, 747 F.2d 703, 706, 223 USPQ 1257, 1259 (Fed. Cir. 1984). Therefore, we can not agree with the examiner’s position (Final Rejection, page 8) that “[r]egardless of use, it is the compound structures and compositions comprising these compound structures that are rendered obvious by the prior art teachings….” Notwithstanding the fact that none of the types of structural similarity referred to above are involved here, the examiner finds (Final Rejection, page 2) that ‘795 teaches “amino acid derivative compounds of generic formula [X-Z-NR2-CHR3- CHOH-(CH2)n-NR4-E-Y] … which are similar to those of the instant claim 1….” According to the examiner (Final Rejection, page 3) “the instant claims … read on the broad genus of compounds and compositions taught by … [‘795].” While appellants do not dispute (Brief, pages 6-7) that their claimed invention overlaps the genus of compounds set forth in ‘795, they point out (Brief, page 8) that the subject matter of ‘795 is directed to rennin inhibitors and not to viral protease inhibitors, a property of the claimed compounds. Here, there is noPage: Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 NextLast modified: November 3, 2007